Literature DB >> 11929756

Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Ombretta Salvucci1, Lei Yao, Sabrina Villalba, Agatha Sajewicz, Stefania Pittaluga, Giovanna Tosato.   

Abstract

The chemokine stromal-derived factor-1 (SDF-1) and its unique receptor, CXCR4, are required for normal cardiovascular development, but a critical role for SDF-1 in postnatal vascular remodeling and the mechanisms underlying SDF-1/CXCR-4 vasculogenesis are unclear. Here we show that SDF-1 is expressed by the vascular endothelium from selected healthy and tumor tissues. In vitro, primary endothelial cells constitutively express SDF-1 that is detected in the cytoplasm, on the cell surface, and in the culture supernatant. Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) increase SDF-1 expression in endothelial cells. In functional studies, pertussis toxin and antibodies to SDF-1 or CXCR-4 disrupt extracellular matrix-dependent endothelial cell tube formation in vitro. This morphogenic process is associated with time-dependent modulation of surface CXCR-4 expression that changes from being diffuse to being polarized and subsequently lost. In vivo, pertussis toxin and neutralizing antibodies directed at SDF-1 inhibit growth factor-dependent neovascularization. These results indicate that SDF-1/CXCR-4 identifies VEGF- and bFGF-regulated autocrine signaling systems that are essential regulators of endothelial cell morphogenesis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929756     DOI: 10.1182/blood.v99.8.2703

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  114 in total

1.  Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.

Authors:  Wei Zhu; Gang Liang; Zhiping Huang; Stephen B Doty; Adele L Boskey
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.

Authors:  Young H Choi; Marie D Burdick; Brett A Strieter; Borna Mehrad; Robert M Strieter
Journal:  Mol Cancer Res       Date:  2013-09-11       Impact factor: 5.852

3.  EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

Authors:  Ombretta Salvucci; Maria de la Luz Sierra; Jose A Martina; Peter J McCormick; Giovanna Tosato
Journal:  Blood       Date:  2006-07-13       Impact factor: 22.113

4.  Characterization of the CXCR4 signaling in pancreatic cancer cells.

Authors:  Daniel D Billadeau; Subrha Chatterjee; Patricia Bramati; Raghavakaimal Sreekumar; Vijay Shah; Karen Hedin; Raul Urrutia
Journal:  Int J Gastrointest Cancer       Date:  2006

5.  EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.

Authors:  Ombretta Salvucci; Dragan Maric; Matina Economopoulou; Shuhei Sakakibara; Simone Merlin; Antonia Follenzi; Giovanna Tosato
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

6.  Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.

Authors:  Krishna Reddy; Zhichao Zhou; Shu-Fang Jia; Tim H Lee; Jaime Morales-Arias; Ying Cao; Eugenie S Kleinerman
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

7.  B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis.

Authors:  Kieron Dunleavy; Frances Hakim; Hyun Kyung Kim; John E Janik; Nicole Grant; Takayuki Nakayama; Therese White; George Wright; Larry Kwak; Ronald Gress; Giovanna Tosato; Wyndham H Wilson
Journal:  Blood       Date:  2005-02-17       Impact factor: 22.113

8.  FGF2 posttranscriptionally down-regulates expression of SDF1 in bone marrow stromal cells through FGFR1 IIIc.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Giovanna Tosato
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

9.  Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease.

Authors:  Aaron M Havens; Evonne Chiu; Mario Taba; Jincheng Wang; Yusuke Shiozawa; Younghun Jung; L Susan Taichman; Nisha J D'Silva; R Gopalakrishnan; CunYu Wang; William V Giannobile; Russell S Taichman
Journal:  J Periodontol       Date:  2008-05       Impact factor: 6.993

10.  Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.

Authors:  Sally K Martin; Peter Diamond; Sharon A Williams; Luen Bik To; Daniel J Peet; Nobutaka Fujii; Stan Gronthos; Adrian L Harris; Andrew C W Zannettino
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.